(Q43040833)

English

Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients

scientific article published on 27 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

0 references

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Tatsuya Kanto

1

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Michiyo Inoue

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tsugiko Oze

3

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Masanori Miyazaki

4

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Mitsuru Sakakibara

5

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Naruyasu Kakita

6

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tokuhiro Matsubara

7

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Koyo Higashitani

8

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Hideki Hagiwara

9

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sadaharu Iio

10

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Kazuhiro Katayama

11

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Eiji Mita

12

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Akinori Kasahara

13

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Naoki Hiramatsu

14

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Tetsuo Takehara

15

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Norio Hayashi

16

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

27 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

169-178

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Treatment options for patients with chronic hepatitis C not responding to initial antiviral therapy

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Antiviral therapy for chronic hepatitis C: past, present, and future

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Treatment of hepatitis C virus: the first decade

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40 KD)/ribavirin.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Immunopathogenesis of hepatitis C virus infection: multifaceted strategies subverting innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Peginterferon alone or with ribavirin enhances HCV-specific CD4 T-helper 1 responses in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Early viraemia clearance during antiviral therapy of chronic hepatitis C improves dendritic cell functions

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Standardization of hepatitis C virus RNA quantification

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Pegylated interferon alpha-2b (Peg-IFN alpha-2b) affects early virologic response dose-dependently in patients with chronic hepatitis C genotype 1 during treatment with Peg-IFN alpha-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Ribavirin dose reduction raises relapse rate dose-dependently in genotype 1 patients with hepatitis C responding to pegylated interferon alpha-2b plus ribavirin

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Prospective analysis of effector and regulatory CD4+ T cells in chronic HCV patients undergoing combination antiviral therapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Interferon signaling and treatment outcome in chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Impaired plasmacytoid dendritic cell maturation and differential chemotaxis in chronic hepatitis C virus: associations with antiviral treatment outcomes

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Altered chemotactic response of myeloid and plasmacytoid dendritic cells from patients with chronic hepatitis C: role of alpha interferon

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Predictive factors of early and sustained responses to peginterferon plus ribavirin combination therapy in Japanese patients infected with hepatitis C virus genotype 1b: amino acid substitutions in the core region and low-density lipoprotein cholest

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0466-Y

21 January 2018

Differential regulation of human blood dendritic cell subsets by IFNs

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing pattern of epidemiology in hepatocellular carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between regulatory T cells and the combination of pegylated interferon and ribavirin for the treatment of chronic hepatitis type C.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of T- and B-lymphocyte subpopulations, CD81 expression levels on B cells and regulatory CD4(+) CD25(+) CD127(low/-) FoxP3(+) T cells in patients with chronic HCV infection during pegylated interferon-alpha2a plus ribavirin treatm

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Classification of chronic hepatitis: diagnosis, grading and staging

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired allostimulatory capacity of peripheral blood dendritic cells recovered from hepatitis C virus-infected individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/21947705

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00535-011-0466-Y

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

12 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43040833&oldid=1978320383"